Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
MONTREAL, Nov. 17, 2016 -- Ropack Pharma Solutions announces it will launch an international serialization hub as a practical solution for pharmaceutical organizations and contract packaging partners that are not serialization-ready by the Drug Supply Chain Security Act (DSCSA) mandated deadline.
Through the serialization hub, packaged pharmaceutical products are sent by an organization’s in-house packaging team or contract partners to Ropack’s Montreal facility. There the packaged products are serialized as required – to the product, the carton or the palette. The serialized product is then shipped, as directed, to a distribution network in the U.S. or Canada, a warehouse for aggregation with other orders or to international destinations which have already adopted serialization.
“Our serialization hub is an efficient alternative,” notes Paul Dupont, Ropack’s VP of Marketing and Business Development. “Becoming serialization-ready is a complex, time-consuming and expensive undertaking which is not practical for every company.” Dupont points out that his company’s serialization hub reduces an organization’s capital expenditures, need for increased personnel and the multifaceted coordination serialization requires.
“A significant benefit is that pharma companies can continue to use their trusted contract packagers – or in-house team – then outsource the serialization component to Ropack.”
According to Dupont, an added benefit is that international shipping from Canada is significantly easier than from the U.S.
Ropack Pharma Solutions (RPS) brings solid oral dosage packaging solutions to leading pharmaceutical and natural health organizations: bottle, flip-top vial, blister (cold formed and thermoformed), stick-packs, sachets, strip-packs. RPS's International Serialization Hub will provide a practical solution for organizations not serialization-ready by November 2017. Headquartered in Montreal, RPS offers the highest level of quality along with gold-standard technology and a responsive, cross-trained staff. Since 1976.
Contact: Paul Dupont, VP Marketing and Business Development Ropack, Inc. [email protected] 513.846.0921
